nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—lung cancer—thymus cancer	0.865	1	CtDrD
Irinotecan—BCHE—diaphragm—thymus cancer	0.00585	0.122	CbGeAlD
Irinotecan—Ischaemia—Octreotide—thymus cancer	0.00557	0.0642	CcSEcCtD
Irinotecan—Rectal disorder—Octreotide—thymus cancer	0.00415	0.0478	CcSEcCtD
Irinotecan—Anorectal disorder—Octreotide—thymus cancer	0.00387	0.0446	CcSEcCtD
Irinotecan—Abdominal cramps—Octreotide—thymus cancer	0.00301	0.0347	CcSEcCtD
Irinotecan—Intestinal obstruction—Octreotide—thymus cancer	0.00298	0.0344	CcSEcCtD
Irinotecan—Neoplasm malignant—Octreotide—thymus cancer	0.00238	0.0274	CcSEcCtD
Irinotecan—Extravasation—Octreotide—thymus cancer	0.00233	0.0269	CcSEcCtD
Irinotecan—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00224	0.0258	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00203	0.0234	CcSEcCtD
Irinotecan—TOP1MT—thyroid gland—thymus cancer	0.00202	0.0422	CbGeAlD
Irinotecan—TOP1MT—lung—thymus cancer	0.00183	0.0383	CbGeAlD
Irinotecan—Thrombophlebitis—Octreotide—thymus cancer	0.0017	0.0196	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0017	0.0196	CcSEcCtD
Irinotecan—CES1—neck—thymus cancer	0.00167	0.0349	CbGeAlD
Irinotecan—Injury—Octreotide—thymus cancer	0.00161	0.0185	CcSEcCtD
Irinotecan—Visual disturbance—Octreotide—thymus cancer	0.00156	0.0179	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Octreotide—thymus cancer	0.00152	0.0176	CcSEcCtD
Irinotecan—CES2—hematopoietic system—thymus cancer	0.00151	0.0316	CbGeAlD
Irinotecan—Osteoarthritis—Octreotide—thymus cancer	0.00148	0.017	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00148	0.017	CcSEcCtD
Irinotecan—Dehydration—Octreotide—thymus cancer	0.00137	0.0158	CcSEcCtD
Irinotecan—Cramp muscle—Octreotide—thymus cancer	0.00133	0.0153	CcSEcCtD
Irinotecan—Abdominal distension—Octreotide—thymus cancer	0.00128	0.0148	CcSEcCtD
Irinotecan—UGT1A1—hematopoietic system—thymus cancer	0.00128	0.0268	CbGeAlD
Irinotecan—TOP1—cardiac atrium—thymus cancer	0.00126	0.0264	CbGeAlD
Irinotecan—TOP1MT—lymph node—thymus cancer	0.00125	0.0262	CbGeAlD
Irinotecan—Pancreatitis—Octreotide—thymus cancer	0.00125	0.0144	CcSEcCtD
Irinotecan—CES1—hematopoietic system—thymus cancer	0.00124	0.026	CbGeAlD
Irinotecan—Sweating increased—Octreotide—thymus cancer	0.00124	0.0143	CcSEcCtD
Irinotecan—TOP1—pituitary gland—thymus cancer	0.00123	0.0258	CbGeAlD
Irinotecan—Upper respiratory tract infection—Octreotide—thymus cancer	0.00119	0.0137	CcSEcCtD
Irinotecan—Weight decreased—Octreotide—thymus cancer	0.00115	0.0133	CcSEcCtD
Irinotecan—CES2—cardiac atrium—thymus cancer	0.00115	0.024	CbGeAlD
Irinotecan—Pneumonia—Octreotide—thymus cancer	0.00114	0.0132	CcSEcCtD
Irinotecan—CES2—pituitary gland—thymus cancer	0.00112	0.0234	CbGeAlD
Irinotecan—Jaundice—Octreotide—thymus cancer	0.00111	0.0128	CcSEcCtD
Irinotecan—SLCO1B1—hematopoietic system—thymus cancer	0.00107	0.0223	CbGeAlD
Irinotecan—TOP1—bone marrow—thymus cancer	0.00107	0.0223	CbGeAlD
Irinotecan—TOP1—thyroid gland—thymus cancer	0.00106	0.0223	CbGeAlD
Irinotecan—Bradycardia—Octreotide—thymus cancer	0.00104	0.012	CcSEcCtD
Irinotecan—Rhinitis—Octreotide—thymus cancer	0.00102	0.0118	CcSEcCtD
Irinotecan—Visual impairment—Octreotide—thymus cancer	0.000984	0.0113	CcSEcCtD
Irinotecan—CES2—bone marrow—thymus cancer	0.000967	0.0202	CbGeAlD
Irinotecan—TOP1—lung—thymus cancer	0.000966	0.0202	CbGeAlD
Irinotecan—CES2—thyroid gland—thymus cancer	0.000965	0.0202	CbGeAlD
Irinotecan—Flushing—Octreotide—thymus cancer	0.000947	0.0109	CcSEcCtD
Irinotecan—Cardiac disorder—Octreotide—thymus cancer	0.000947	0.0109	CcSEcCtD
Irinotecan—Immune system disorder—Octreotide—thymus cancer	0.000922	0.0106	CcSEcCtD
Irinotecan—Arrhythmia—Octreotide—thymus cancer	0.000912	0.0105	CcSEcCtD
Irinotecan—Alopecia—Octreotide—thymus cancer	0.000902	0.0104	CcSEcCtD
Irinotecan—CES2—lung—thymus cancer	0.000876	0.0183	CbGeAlD
Irinotecan—Flatulence—Octreotide—thymus cancer	0.000876	0.0101	CcSEcCtD
Irinotecan—CES1—lymphoid tissue—thymus cancer	0.000875	0.0183	CbGeAlD
Irinotecan—SLC22A3—hematopoietic system—thymus cancer	0.000862	0.018	CbGeAlD
Irinotecan—Back pain—Octreotide—thymus cancer	0.00086	0.00991	CcSEcCtD
Irinotecan—Muscle spasms—Octreotide—thymus cancer	0.000854	0.00985	CcSEcCtD
Irinotecan—Ill-defined disorder—Octreotide—thymus cancer	0.000825	0.0095	CcSEcCtD
Irinotecan—Anaemia—Octreotide—thymus cancer	0.000821	0.00947	CcSEcCtD
Irinotecan—Malaise—Octreotide—thymus cancer	0.000801	0.00924	CcSEcCtD
Irinotecan—Vertigo—Octreotide—thymus cancer	0.000798	0.0092	CcSEcCtD
Irinotecan—Syncope—Octreotide—thymus cancer	0.000797	0.00919	CcSEcCtD
Irinotecan—ACHE—thyroid gland—thymus cancer	0.000795	0.0166	CbGeAlD
Irinotecan—CES1—thyroid gland—thymus cancer	0.000795	0.0166	CbGeAlD
Irinotecan—Loss of consciousness—Octreotide—thymus cancer	0.000781	0.009	CcSEcCtD
Irinotecan—Cough—Octreotide—thymus cancer	0.000775	0.00894	CcSEcCtD
Irinotecan—Hypertension—Octreotide—thymus cancer	0.000767	0.00884	CcSEcCtD
Irinotecan—Discomfort—Octreotide—thymus cancer	0.000748	0.00862	CcSEcCtD
Irinotecan—Anaphylactic shock—Octreotide—thymus cancer	0.000725	0.00836	CcSEcCtD
Irinotecan—Oedema—Octreotide—thymus cancer	0.000725	0.00836	CcSEcCtD
Irinotecan—CES1—lung—thymus cancer	0.000722	0.0151	CbGeAlD
Irinotecan—Infection—Octreotide—thymus cancer	0.000721	0.0083	CcSEcCtD
Irinotecan—Shock—Octreotide—thymus cancer	0.000714	0.00822	CcSEcCtD
Irinotecan—Nervous system disorder—Octreotide—thymus cancer	0.000711	0.0082	CcSEcCtD
Irinotecan—Thrombocytopenia—Octreotide—thymus cancer	0.00071	0.00818	CcSEcCtD
Irinotecan—Hyperhidrosis—Octreotide—thymus cancer	0.000701	0.00808	CcSEcCtD
Irinotecan—Anorexia—Octreotide—thymus cancer	0.000691	0.00797	CcSEcCtD
Irinotecan—TOP1—lymph node—thymus cancer	0.000661	0.0138	CbGeAlD
Irinotecan—Insomnia—Octreotide—thymus cancer	0.000656	0.00756	CcSEcCtD
Irinotecan—Paraesthesia—Octreotide—thymus cancer	0.000651	0.00751	CcSEcCtD
Irinotecan—Dyspnoea—Octreotide—thymus cancer	0.000647	0.00745	CcSEcCtD
Irinotecan—Somnolence—Octreotide—thymus cancer	0.000645	0.00743	CcSEcCtD
Irinotecan—Dyspepsia—Octreotide—thymus cancer	0.000638	0.00736	CcSEcCtD
Irinotecan—Decreased appetite—Octreotide—thymus cancer	0.00063	0.00727	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Octreotide—thymus cancer	0.000626	0.00722	CcSEcCtD
Irinotecan—Fatigue—Octreotide—thymus cancer	0.000625	0.00721	CcSEcCtD
Irinotecan—Pain—Octreotide—thymus cancer	0.00062	0.00715	CcSEcCtD
Irinotecan—Constipation—Octreotide—thymus cancer	0.00062	0.00715	CcSEcCtD
Irinotecan—BCHE—hematopoietic system—thymus cancer	0.000611	0.0128	CbGeAlD
Irinotecan—CES2—lymph node—thymus cancer	0.000599	0.0125	CbGeAlD
Irinotecan—Feeling abnormal—Octreotide—thymus cancer	0.000598	0.00689	CcSEcCtD
Irinotecan—Gastrointestinal pain—Octreotide—thymus cancer	0.000593	0.00684	CcSEcCtD
Irinotecan—Abdominal pain—Octreotide—thymus cancer	0.000573	0.00661	CcSEcCtD
Irinotecan—Body temperature increased—Octreotide—thymus cancer	0.000573	0.00661	CcSEcCtD
Irinotecan—SLC22A3—thyroid gland—thymus cancer	0.000551	0.0115	CbGeAlD
Irinotecan—CYP3A5—hematopoietic system—thymus cancer	0.000548	0.0115	CbGeAlD
Irinotecan—CYP2B6—hematopoietic system—thymus cancer	0.000545	0.0114	CbGeAlD
Irinotecan—ABCC1—cardiac atrium—thymus cancer	0.000541	0.0113	CbGeAlD
Irinotecan—Hypersensitivity—Octreotide—thymus cancer	0.000534	0.00616	CcSEcCtD
Irinotecan—ABCC1—pituitary gland—thymus cancer	0.000529	0.0111	CbGeAlD
Irinotecan—Asthenia—Octreotide—thymus cancer	0.00052	0.006	CcSEcCtD
Irinotecan—SLC22A3—lung—thymus cancer	0.000501	0.0105	CbGeAlD
Irinotecan—Diarrhoea—Octreotide—thymus cancer	0.000496	0.00572	CcSEcCtD
Irinotecan—CES1—lymph node—thymus cancer	0.000494	0.0103	CbGeAlD
Irinotecan—ACHE—lymph node—thymus cancer	0.000494	0.0103	CbGeAlD
Irinotecan—Dizziness—Octreotide—thymus cancer	0.00048	0.00553	CcSEcCtD
Irinotecan—BCHE—cardiac atrium—thymus cancer	0.000464	0.0097	CbGeAlD
Irinotecan—Vomiting—Octreotide—thymus cancer	0.000461	0.00532	CcSEcCtD
Irinotecan—Rash—Octreotide—thymus cancer	0.000457	0.00527	CcSEcCtD
Irinotecan—Dermatitis—Octreotide—thymus cancer	0.000457	0.00527	CcSEcCtD
Irinotecan—ABCC1—thyroid gland—thymus cancer	0.000456	0.00954	CbGeAlD
Irinotecan—Headache—Octreotide—thymus cancer	0.000454	0.00524	CcSEcCtD
Irinotecan—BCHE—pituitary gland—thymus cancer	0.000453	0.00948	CbGeAlD
Irinotecan—ABCG2—pituitary gland—thymus cancer	0.000438	0.00916	CbGeAlD
Irinotecan—Nausea—Octreotide—thymus cancer	0.000431	0.00497	CcSEcCtD
Irinotecan—ABCC1—lung—thymus cancer	0.000414	0.00866	CbGeAlD
Irinotecan—CYP3A4—hematopoietic system—thymus cancer	0.000411	0.0086	CbGeAlD
Irinotecan—BCHE—bone marrow—thymus cancer	0.000392	0.00819	CbGeAlD
Irinotecan—BCHE—thyroid gland—thymus cancer	0.000391	0.00817	CbGeAlD
Irinotecan—CYP2B6—lymphoid tissue—thymus cancer	0.000383	0.00802	CbGeAlD
Irinotecan—ABCG2—bone marrow—thymus cancer	0.000378	0.00792	CbGeAlD
Irinotecan—ABCG2—thyroid gland—thymus cancer	0.000377	0.0079	CbGeAlD
Irinotecan—BCHE—lung—thymus cancer	0.000355	0.00742	CbGeAlD
Irinotecan—ALB—lymph node—thymus cancer	0.000343	0.00718	CbGeAlD
Irinotecan—ABCG2—lung—thymus cancer	0.000343	0.00717	CbGeAlD
Irinotecan—SLC22A3—lymph node—thymus cancer	0.000343	0.00717	CbGeAlD
Irinotecan—ABCC2—lymph node—thymus cancer	0.000322	0.00673	CbGeAlD
Irinotecan—CYP3A5—lung—thymus cancer	0.000318	0.00666	CbGeAlD
Irinotecan—CYP2B6—lung—thymus cancer	0.000316	0.00662	CbGeAlD
Irinotecan—ABCB1—hematopoietic system—thymus cancer	0.000291	0.00609	CbGeAlD
Irinotecan—ABCC1—lymph node—thymus cancer	0.000283	0.00592	CbGeAlD
Irinotecan—ABCB1—epithelium—thymus cancer	0.000266	0.00557	CbGeAlD
Irinotecan—BCHE—lymph node—thymus cancer	0.000243	0.00507	CbGeAlD
Irinotecan—ABCG2—lymph node—thymus cancer	0.000234	0.0049	CbGeAlD
Irinotecan—ABCB1—pituitary gland—thymus cancer	0.000216	0.00452	CbGeAlD
Irinotecan—ABCB1—lymphoid tissue—thymus cancer	0.000205	0.00429	CbGeAlD
Irinotecan—ABCB1—bone marrow—thymus cancer	0.000187	0.0039	CbGeAlD
Irinotecan—ABCB1—thyroid gland—thymus cancer	0.000186	0.00389	CbGeAlD
Irinotecan—ABCB1—lung—thymus cancer	0.000169	0.00354	CbGeAlD
Irinotecan—ABCB1—lymph node—thymus cancer	0.000116	0.00242	CbGeAlD
